Previous 10 | Next 10 |
Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...
Shares of Semler Scientific (NASDAQ: SMLR) were sinking 23.1% as of 10:33 a.m. ET on Tuesday. The steep decline came after the medical technology company reported its first-quarter results following the market close on Monday. Semler announced Q1 revenue of $14 million, up 6% ye...
Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...
Semler Scientific, Inc. (SMLR) Q1 2022 Earnings Conference Call May 02, 2022, 10:30 AM ET Company Participants Douglas Murphy-Chutorian - CEO Dennis Rosenberg - Chief Marketing Officer Andrew Weinstein - SVP, Finance and Accounting Conference Call Participants Brooks O’Neil - Lake Stre...
Shares of Semler Scientific (NASDAQ:SMLR) dropped 10% in post-market trading after the healthcare technology products company reported Q1 2021 earnings that missed on the top and bottom lines. Q1 GAAP EPS of $0.41 missed by $0.07 while revenue of ~$14M, a 6.2% year-over-ye...
Semler Scientific (NASDAQ:SMLR): Q1 GAAP EPS of $0.41 Revenue of $14.02M (+6.2% Y/Y) Up to $20.0M stock buyback program initiated Q2 revenue will range from $14.2M-15.2M FY22 revenue will range from $58.0M-60.0M Shares +3.09%. Source: press release For further details see: Semler S...
Semler Reports First Quarter 2022 Financial Results PR Newswire 2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million , an increase of $0.8 million , or 6%, compared to $13.2 million Net income was $3...
Semler Scientific has been sold off since its Q3 and Q4 earnings misses, down 67% from November 2021 levels. Semler is tackling massive healthcare problems such as PAD, diabetes, and Alzheimer's. Its flagship QuantaFlo product is a fundamentally superior product that tests for PAD...
Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022 PR Newswire SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve ...
The following slide deck was published by Semler Scientific, Inc. in conjunction with this event. For further details see: Semler Scientific (SMLR) Investor Presentation -Slideshow
News, Short Squeeze, Breakout and More Instantly...
Semler Scientific Inc Company Name:
SMLR Stock Symbol:
OTCMKTS Market:
Semler Scientific Inc Website:
Semler Scientific to Report Second Quarter and First Half of 2024 Financial Results and Host Conference Call on August 5, 2024 PR Newswire SANTA CLARA, Calif. , July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and mark...
2024-06-24 16:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Semler Scientific® Announces Additional Bitcoin Purchases PR Newswire SANTA CLARA, Calif. , June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to...